(Q43266783)
Statements
1 reference
Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy (English)
1 reference
Jørn Herrstedt
1 reference
Wichit Apornwirat
1 reference
Ahmed Shaharyar
1 reference
Zeba Aziz
1 reference
Fausto Roila
1 reference
Simon Van Belle
1 reference
Mark W Russo
1 reference
Jeremey Levin
1 reference
Salabha Ranganathan
1 reference
Mary Guckert
1 reference
Steven M Grunberg
1 reference
5 October 2009
1 reference
1 reference
27
1 reference
32
1 reference
5363-5369
1 reference
Identifiers
1 reference
1 reference